Ultrasonographic Evaluation of Parasternal Intercostal Muscles in Stroke Patients

ConditionsStroke Respiratory Muscle

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age30-90

SponsorFatih Sultan Mehmet Training and Research Hospital

About this trial

Ultrasonographic evaluation of parasternal intercostal muscles and to determine whether there is a correlation with PFT parameters in stroke patients

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Ischemic or Hemorrhagic stroke patients, Stroke duration >6 months, Mini-mental test score >24

Disqualifiers

Individuals with acute or chronic lung disease, Patients with a history of thoracic or abdominal surgery, Patients with other neuromuscular diseases, Aphasia type with impaired understanding, Facial paralysis

Trial population

Stroke patients and healthy volunteers (have close demographic data with stroke patients)

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

Parasternal intercostal muscle thickness with ultrasonography
Diagnostic test
Ultrasonographic measurements were performed of the bilateral parasternal intercostal muscle thickness in the supine position in the stroke patient group. Ultrasonographic measurements were performed of dominant side parasternal intercostal muscle thickness in the supine position in healthy individuals group. Spirometry evaluation was performed in both groups.

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: Stroke patients1 intervention

Group B: Healthy individuals1 intervention

Trial outcomes

Primary outcomes

Parasternal intercostal muscle thickness and thickening ratio

Parasternal intercostal muscle ultrasonographic millimetric measurement

Time frame

15 minute

Secondary outcomes

Correlation between parasternal intercostal muscle thicknesses and spirometry parameters

Vital capacity\[VC\], forced vital capacity \[FVC\], forced expiratory volume 1 second \[FEV1\] , FEV1/FVC, maximal expiratory flow rate \[PEF\], maximum inspiratory pressure \[MIP\] maximum expiratory pressure \[MEP\] in patients' PFT \]

Time frame

15 minute

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fatih Sultan Mehmet Training and Research Hospital

Lead sponsor

Source ClinicalTrials.gov

Apply now